Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Apricus Biosciences -- Ignore unavailable to you. Want to Upgrade?

To: Strong Long who wrote (1569)	11/19/2015 6:55:05 PM
From: phoenix_rising	Respond to of 2026

I still believe this is a good deal as previously they had nothing at all for USA Vitaros. It just isn't as good as I originally thought. From the information Pascoe is putting out, there really isn't going to be much in the way of costs to get US approval, so it is not like they are investing a lot of money in this and the potential returns even if just for %royalties could be quite substantial, especially if the melanoma issue with Viagra gets some traction in the press.